Disease progression in gastro-oesophageal reflux disease as determined by repeat oesophageal pH monitoring and endoscopy 3 to 4.5 years after diagnosis

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue 12, 1997, Pages 1161-1167

  McDougall, Neil I ^a   Johnston, Brian T ^b   Collins, John S A ^c   McFarland, R James ^d   Love, A M Gary ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b Lisburn BT28 1JP   (United Kingdom)

^c ROYAL VICTORIA HOSPITAL   (United Kingdom)

^d ULSTER HOSPITAL   (United Kingdom)

Author keywords

Barrett's oesophagus; Gastro oesophageal reflux; Long term follow up; Oesophageal pH monitoring; Oesophagitis

Indexed keywords

STOMACH SECRETION INHIBITOR;

ARTICLE; BARRETT ESOPHAGUS; DISEASE COURSE; ESOPHAGUS PH; ESOPHAGUS STRICTURE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; PATIENT MONITORING; PRIORITY JOURNAL; QUESTIONNAIRE; REFLUX ESOPHAGITIS; SYMPTOM;

ADULT; AGED; BARRETT ESOPHAGUS; DISEASE PROGRESSION; ENDOSCOPY; ESOPHAGITIS, PEPTIC; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; INTUBATION, GASTROINTESTINAL; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 0031473006     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Kuster E, Ros E, Toledo-Pimentel V, et al.: Predictive factors of the long term outcome in gastro-oesophageal reflux disease: six year follow up of 107 patients. Gut 1994, 35:8-14.
2. Lieberman DA: Medical therapy for chronic reflux esophagitis. Long-term follow-up. Arch Intern Med 1987, 147:1717-1 720.
3. Ollyo JB, Monnier P, Fontolliet C, et al.: The natural history, prevalence and incidence of reflux oesophagitis. Gullet 1993, 3(suppl. 1):3-10.
4. Schindlbeck NE, Klauser AG, Berghammer G, et al.: Three year follow-up of patients with gastroesophageal reflux disease. Gut 1992, 33:1016-1019.
5. Pace F, Santalucia F, Bianchi Porro G: Natural history of gastrooesophageal reflux disease without oesophagitis. Gut 1991, 32:845-848.
6. McDougall NI, Johnston BT, Kee F, et al.: Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life. Gut 1996, 38:481-486.
7. Richter JE, Castell DO: Gastroesophageal reflux: pathogenesis, diagnosis and therapy. Ann Intern Med 1982, 97:93-103.
8. Little AG, De Meester TR, Kirchner PT, et al.: Pathogenesis of esophagitis in patients with gastroesophageal reflux. Surgery 1980, 88:101-107.
9. Eriksen CA, Cuschieri A: Diagnostic tests for gastro-oesophageal reflux disease. In Reflux Oesophagitis. Edited by Hennessy TPJ, Cuschieri A, Bennett JR. London: Butterworths; 1989:55-86.
10. Blackwell JN: Investigation of the oesophagus. In Diseases of the Gut and Pancreas, 2nd edn. Edited by Misiewicz JJ, Pounder RE, Venables CW. Oxford: Blackwell Scientific Publications; 1994:115-122.
11. Trimble KC, Douglas S, Pryde A, et al.: Clinical characteristics and natural history of symptomatic but not excess gastroesophageal reflux. Dig Dis Sci 1995, 40:1098-1104.
12. Jamieson JR, Stein HJ, DeMeester TR, et al.: Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 1992, 87:1102-1111.
13. Armstrong D, Bennett JR, Blum AL, et al.: The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996, 111:85-92.
14. Johnston BT, McFarland RJ, Collins JSA, et al.: The symptom index: a useful marker of gastro-oesophageal reflux disease. Br J Surg 1992, 79:1054-1035.
15. Dent J, Yeomans ND, Mackinnon M, et al.: Omeprazole vs ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety. Gut 1994, 35:590-598.
16. Lundell L, Backman L, Ekstrom P, et al.: Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine. Scand J Gastroenterol 1991, 26:248-256.
17. Klauser AG, Schindlbeck NE, Muller-Lissner SA: Symptoms in gastro-oesophageal reflux disease. Lancet 1990, 335:205-208.
18. Johansson K-E, Ask P, Boeryd B, et al.: Oesophagitis, signs of reflux and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. Scand J Gastroenterol 1986, 21:837-047.
19. Knill-Jones RP, Card WI, Crean GP, et al.: The symptoms of gastro-oesophageal reflux and of oesophagitis. Scand J Gastroenterol 1984, 19(suppl. 106):72-76.
20. Eriksen CA, Cullen PT, Sutton D, et al.: Abnormal esophageal transit in patients with typical reflux symptoms but normal endoscopic and pH profiles. Am J Surg 1991, 161:657-661.
21. Hallerback B, Unge P, Carling L, et al.: Omeprazole or ranitidine in long-term treatment of reflux esophagitis. Gastroenterology 1994, 107:1305-1311.
22. Dent J, Hetzel DJ, Mackinnon MA, et al.: Evaluation of omeprazole in reflux oesophagitis. Scand J Gastroenterol 1989, 24(suppl. 166):76-82.
23. Koelz HR, Birchler R, Bretholz A, et al.: Healing and relapse of reflux esophagitis during treatment with ranitidine. Gastroenterology 1986, 91:1198-1205.
24. Spechler SJ: Epidemiology and natural history of gastrooesophageal reflux disease. Digestion 1992, 51(suppl. 11):24-29.
25. Klinkenberg-Knol EC, Festen HPM, Jansen JBMJ, et al.: Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med 1994, 121:161-167.
26. Isolauri J, Luostarinen M, Isolauri E, et al.: Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients. Am J Gastroenterol 1997, 92:37-41.
27. Hampton FJ, MacFadyen UM, Mayberry JF: Variations in results of simultaneous ambulatory esophageal pH monitoring. Dig Dis Sci 1992, 37:506-512.
28. Johnsson F, Joelsson B: Reproducibility of ambulatory oesophageal pH monitoring. Gut 1988, 29:886-889.
29. Murphy DW, Yuan Y, Castell DO: Does the intraesophageal pH probe accurately detect acid reflux? Simultaneous recording with two pH probes in humans. Dig Dis Sci 1989, 34:649-656.
30. McDougall NI: Diagnosis of reflux disease. Ir J Med Sci 1996, 165:1-6.
31. Wiener GJ, Morgan TM, Copper JB, et al.: Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci 1988, 33:1127-1133.
32. Gillen P, Hennessy TPJ: Barrett's oesophagus. In Reflux Oesophagitis. Edited by Hennessy TPJ, Cuschieri A, Bennett JR. London: Butterworths; 1989:87-111.
33. Brossard E, Monnier P, Ollyo J-B, et al.: Serious complications -stenosis, ulcer and Barrett's epithelium - develop in 21.6% of adults with erosive reflux oesophagitis. Gastroenterology 1991, 100(2):A36.
34. Cameron AJ, Lomboy CT: Barrett's esophagus: age, prevalence and extent of columnar epithelium. Gastroenterology 1992, 103:1241-1245.
35. Spechler SJ, Zeroogian JM, Antonioli DA, et al.: Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1995, 344:1533-1536.
36. Cameron AJ, Kamath PS, Carpenter HC: Barrett's esophagus. The prevalence of short and long segments in reflux patients [abstract]. Gastroenterology 1995, 108(4):A65.
37. Johnsson F, Joelsson B, Gudmundsson K, et al.: Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease. Scand J Gastroenterol 1987, 22:714-718.
38. Jensen G. Epidemiology of chest pain and angina pectoris. Acta Med Scand 1984, suppl. 682:13-19.